Answers are grounded in this paper and cite their sources.
Patients with Cushing's disease and comorbid hypertension/diabetes receiving osilodrostat had rapid and sustained improvements in SBP/DBP and glycemic control, respectively.
No takes yet. Share an insight, caveat, or question.
Fleseriu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: